1st Quarter - Report

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
—
Expenses
$6,910,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation S. 369, Preserve Access to Affordable Generics Act: patent settlements S. 515, Patent Reform Act of 2009: reforms of the patent laws S. 560, Patent Reform Act of 2009: reforms of the patent laws S. 610, Patent Reform Act of 2009: reforms of the patent laws S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics International intellectual property issues

LobbyistCovered position, as disclosed
DAVID BOYER New Special Assist. to the President for Legislative, Affairs - White House, Assist. Comm'r for, Legislation - FDA, Special Assist. for Over-, sight - HHS, Special Assist. to the Secretary -, HHS, Special Assist. in Office of Assist., Secretary for Legislation - HHS, Special Assist., in Office of White House Liaison - Dept. of, Defense, Confidential Assist. in Office of, Secretary - Dept. of Labor
ROBERT FILIPPONE —
JAMES BRYANT HALL —
MIMI KNEUER —
DAVID KORN —
HALLIE AMANDA MARANCHICK —
KENDRA MARTELLO —
BYRON PATTERSON —
RICHARD SMITH —
HEATHER STRAWN —
MATTHEW L SULKALA Senior Legislative Assistant - Rep. Allen Boyd
JENNIFER ANNE SWENSON New Staff Assist., Legis. Correspondent, Legis., Assist., Dep. Legis. Director - Sen. Pat Roberts
BILLY TAUZIN —
STEVE TILTON —
BRIAN CHRISTOPHER TOOHEY —
MICHAEL PAUL WOODY Professional Staff - Senate HELP Committee

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); White House Office; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Bills named: H.R. 1548 (111th), S. 515 (111th), H.R. 628 (111th), S. 369 (111th), H.R. 1260 (111th), H.R. 1427 (111th), S. 726 (111th), S. 560 (111th), S. 610 (111th), H.R. 1706 (111th), S. 299 (111th)

Health Issues HCR

H.R. 444, 340B Program Improvement and Integrity Act: 340B program issues H.R. 759, Food and Drug Administration Globalization Act of 2009: import safety H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009: importation H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009: importation S. 717, 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act: reimbursement and clinical trial issues S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics S. 3409, Drug and Device Accountability Act of 2008: import safety Health care reform issues Confirmation of Department of Health and Human Services Secretary

LobbyistCovered position, as disclosed
MAYA BERMINGHAM —
DAVID BOYER New Special Assist. to the President for Legislative, Affairs - White House, Assist. Comm'r for, Legislation - FDA, Special Assist. for Over-, sight - HHS, Special Assist. to the Secretary -, HHS, Special Assist. in Office of Assist., Secretary for Legislation - HHS, Special Assist., in Office of White House Liaison - Dept. of, Defense, Confidential Assist. in Office of, Secretary - Dept. of Labor
RANDY BURKHOLDER —
JAMES BRYANT HALL —
LAURYL DODSON JACKSON —
VALERIE HARDIN JEWETT Legis. Director - Rep. Rodney Frelinghuysen
ANN KAPLAN —
MIMI KNEUER —
DAVID KORN —
HALLIE AMANDA MARANCHICK —
KENDRA MARTELLO —
TOM MOORE —
BRIAN NAGLE —
BYRON PATTERSON —
LORI REILLY —
RICHARD SMITH —
HEATHER STRAWN —
MATTHEW L SULKALA Senior Legislative Assistant - Rep. Allen Boyd
JENNIFER ANNE SWENSON New Staff Assist., Legis. Correspondent, Legis., Assist., Dep. Legis. Director - Sen. Pat Roberts
BILLY TAUZIN —
STEVE TILTON —
MICHAEL PAUL WOODY Professional Staff - Senate HELP Committee

Contacted: Commerce, Dept of (DOC); Agency for Healthcare Research & Quality (AHRQ); Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC)

Bills named: S. 717 (111th), H.R. 1298 (111th), S. 525 (111th), H.R. 1548 (111th), S. 3409 (111th), S. 726 (111th), H.R. 759 (111th), H.R. 444 (111th), H.R. 1427 (111th)

Medicare/Medicaid MMM

H.R. 1, American Recovery and Reinvestment Act of 2009: Medicaid rebate H.R. 2, Childrens Health Insurance Program Reauthorization Act of 2009: SCHIP reauthorization, Medicaid rebate, 340B H.R. 684, Medicare Prescription Drug Savings and Choice Act: Part D issues S. 1, American Recovery and Reinvestment Act of 2009: Medicaid rebate S. 275, Childrens Health Insurance Reauthorization Act of 2009: SCHIP reauthorization, Medicaid rebate S. 301, Physician Payments Sunshine Act of 2009: transparency issues S. 330, Medicare Prescription Drug Savings and Choice Act: Part D issues S. 350, American Recovery and Reinvestment Act of 2009: Medicaid rebate S. 458, False Claims Clarification Act of 2009: liability issues

LobbyistCovered position, as disclosed
DAVID BOYER New Special Assist. to the President for Legislative, Affairs - White House, Assist. Comm'r for, Legislation - FDA, Special Assist. for Over-, sight - HHS, Special Assist. to the Secretary -, HHS, Special Assist. in Office of Assist., Secretary for Legislation - HHS, Special Assist., in Office of White House Liaison - Dept. of, Defense, Confidential Assist. in Office of, Secretary - Dept. of Labor
RANDY BURKHOLDER —
JAMES BRYANT HALL —
LAURYL DODSON JACKSON —
ANN KAPLAN —
MIMI KNEUER —
HALLIE AMANDA MARANCHICK —
TOM MOORE —
BYRON PATTERSON —
RICHARD SMITH —
HEATHER STRAWN —
MATTHEW L SULKALA Senior Legislative Assistant - Rep. Allen Boyd
JENNIFER ANNE SWENSON New Staff Assist., Legis. Correspondent, Legis., Assist., Dep. Legis. Director - Sen. Pat Roberts
BILLY TAUZIN —
STEVE TILTON —
JENNIFER VAN METER —
MICHAEL PAUL WOODY Professional Staff - Senate HELP Committee

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Patent & Trademark Office (PTO); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Commerce, Dept of (DOC)

Bills named: S. 458 (111th), H.R. 1 (111th), S. 1 (111th), H.R. 684 (111th), H.R. 2 (111th), S. 275 (111th), S. 350 (111th), S. 330 (111th), S. 301 (111th)

Budget/Appropriations BUD

H.R. 1, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness research, health information technology, and privacy issues H.R. 1105, Omnibus Appropriations Act, 2009: budget for FDA and HHS S. 1, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness, health information technology, and privacy issues S. 336, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness, health information technology, and privacy issues S.Con.Res.13, 2010 Budget Resolution: health care related provisions H.Con.Res. 85, 2010 Budget Resolution: health care related provisions

LobbyistCovered position, as disclosed
MAYA BERMINGHAM —
DAVID BOYER New Special Assist. to the President for Legislative, Affairs - White House, Assist. Comm'r for, Legislation - FDA, Special Assist. for Over-, sight - HHS, Special Assist. to the Secretary -, HHS, Special Assist. in Office of Assist., Secretary for Legislation - HHS, Special Assist., in Office of White House Liaison - Dept. of, Defense, Confidential Assist. in Office of, Secretary - Dept. of Labor
RANDY BURKHOLDER —
ANDREA JEAN DOUGLAS —
JAMES BRYANT HALL —
VALERIE HARDIN JEWETT Legis. Director - Rep. Rodney Frelinghuysen
ANN KAPLAN —
MIMI KNEUER —
HALLIE AMANDA MARANCHICK —
TOM MOORE —
BRIAN NAGLE —
BYRON PATTERSON —
LORI REILLY —
RICHARD SMITH —
HEATHER STRAWN —
MATTHEW L SULKALA Senior Legislative Assistant - Rep. Allen Boyd
JENNIFER ANNE SWENSON New Staff Assist., Legis. Correspondent, Legis. Assist.,, Deputy Legis. Director - Senator Pat Roberts
BILLY TAUZIN —
STEVE TILTON —
JENNIFER VAN METER —
MICHAEL PAUL WOODY Professional Staff - Senate HELP Committee

Contacted: Congressional Budget Office (CBO); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); White House Office; Patent & Trademark Office (PTO); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 1105 (111th), S.Con.Res. 13 (111th), H.R. 1 (111th), H.Con.Res. 85 (111th), S. 1 (111th), S. 336 (111th)

Trade (domestic/foreign) TRD

H.R. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues S. 336, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues Korea Free Trade Agreement: intellectual property, market access and public health Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues Trade enforcement issues

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
TOM MOORE —
BRIAN CHRISTOPHER TOOHEY —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); SENATE; Congressional Budget Office (CBO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Economic Council (NEC); Agency for Healthcare Research & Quality (AHRQ); White House Office

Bills named: S. 336 (111th), S. 1 (111th), H.R. 1 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.